Who is sponsoring NCT05287087?

NCT05287087 is sponsored by Aarhus University Hospital.

What drugs are being tested in NCT05287087?

Interventions in NCT05287087: My Symptoms 1 (MySt-1), My Symptoms 2 (MySt-2).

What condition does NCT05287087 study?

NCT05287087 studies Persistent Physical Symptoms.

Is NCT05287087 still recruiting?

NCT05287087 is currently completed. Last updated 23 February 2024.

Last reviewed 2024-02-23 · How we verify

NCT05287087

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

My Symptoms - Feasibility Study

Completed NA Last updated 23 February 2024

What this trial tests

NA trial testing My Symptoms 1 (MySt-1) in Persistent Physical Symptoms in 40 participants. Completed in 30 June 2023.

Timeline

31 March 2022

Primary endpoint
30 September 2022

30 June 2023

Quick facts

Lead sponsor	Aarhus University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	40
Start date	31 March 2022
Primary completion	30 September 2022
Estimated completion	30 June 2023
Sites	1 location across Denmark

Drugs / interventions tested

My Symptoms 1 (MySt-1)
My Symptoms 2 (MySt-2)

Conditions studied

Persistent Physical Symptoms — all drugs for Persistent Physical Symptoms →

Sponsor

Aarhus University Hospital

Who can join

Adults 18 to 65, any sex, with Persistent Physical Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed project 'My Symptoms' is part of a large research programme: eHealth and GP-assisted self-help interventions for persistent physical symptoms (eASY). See www.minesymptomer.dk. The research programme is an ambitious and dedicated effort aiming at improvement of functioning and quality of life for individuals with persistent physical symptoms (PPS) and prevention of the development of chronic functional disorders and associated loss of working capacity and high use of health care. At present, access to specialized treatment of PPS is very limited and treatment capacity in general practice is restricted to brief consultations - often with poor opportunity to make a treatment plan for symptoms. In order to improve health care for patients with PPS, the investigators have developed a web-based selfhelp programme for symptoms. As part of the intervention, this programme is prescribed by the patient's general practitioner (GP). The investigators have applied a high degree of user involvement (GPs and patients) in the development process but there is a need to evaluate how the new treatment programme is in fact adopted and how it affects GPs in routine care and patients in daily life. With this study, the investigators wish to take the first step towards a comprehensive and rigorous evaluation. Results from this feasibility study will both qualify a subsequent randomised controlled trial (RCT) in a larger pilot study and provide information for a potential national dissemination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Aarhus University Hospital trials

Trials by the same sponsor.

NCT07432802 — Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer · NA · not yet recruiting
NCT07499336 — UNDERSTANDING THE T-CELL AND B-CELL RECEPTOR REPERTOIRE IN CHILDREN AND YOUNG ADULTS WITH ANTI-DRUG ANTIBODIES AGAINST P · not yet recruiting
NCT07454486 — TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cance · not yet recruiting
NCT07284069 — Senicapoc and Perampanel for Newly Diagnosed Glioblastoma · EARLY_PHASE1 · recruiting
NCT07426250 — Clinical Utility of ctDNA in the Treatment of Oligometastatic Disease · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05287087 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aarhus University Hospital
Last refreshed: 23 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05287087.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing